SOHM, Inc. (SHMN)
OTCMKTS · Delayed Price · Currency is USD
0.0009
-0.0001 (-5.26%)
Feb 9, 2026, 3:28 PM EST
SOHM, Inc. Revenue
In the year 2012, SOHM, Inc. had annual revenue of $1.30M, down -3.27%. SOHM, Inc. had revenue of $291.24K in the quarter ending December 31, 2012, with 35.18% growth.
Revenue
1.30M
Revenue Growth
+115.16%
P/S Ratio
2.01
Revenue / Employee
8.94K
Employees
145
Market Cap
2.61M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 1.30M | -43.89K | -3.27% |
| Dec 31, 2011 | 1.34M | 558.67K | 71.47% |
| Dec 31, 2010 | 781.68K | 586.77K | 301.06% |
| Dec 31, 2009 | 194.90K | -127.44K | -39.53% |
| Dec 31, 2008 | 322.34K | 317.32K | 6,322.41% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Eagle Pharmaceuticals | 257.55M |
| Trees | 14.50M |
| Panacea Life Sciences Holdings | 2.76M |
| CannaPharmaRX | 1.71M |
| For The Earth | 687.89K |
| Bio Essence | 565.67K |
| Redwood Scientific Technologies | 259.71K |
| Indo Global Exchange(s) PTE | 3.49K |
SOHM, Inc. News
- 3 months ago - SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery - Accesswire
- 3 months ago - SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development - Accesswire
- 5 months ago - SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea - Accesswire
- 5 months ago - SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility - Accesswire
- 6 months ago - SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities - Accesswire
- 7 months ago - SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement - Accesswire
- 8 months ago - SOHM, Inc. Appoints Ravi Kapoor as an Independent Director - Accesswire
- 8 months ago - SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market - Accesswire